weight management Semaglutide is FDA-approved for two separate conditions with different maximum doses
One 2025 clinical review in Biomolecules reported people who take GLP-1s as obesity treatments lose an average of 15% to 25% of their body weight after the first year
allergic reaction symptoms (rash, swelling, breathing difficulty)
Using bacteriostatic water rather than sterile water extends shelf life and reduces contamination risk
Tirzepatide and semaglutide are generally safe, but they may not be suitable for everyone, including: People with a personal or family history of thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN2) People with a personal or family history of pancreatitis People with known hypersensitivity to any component of the medication People who are pregnant, breastfeeding, and planning to become pregnant Always consult a healthcare provider before starting a new medication
Over-the-counter non-sedating antihistamines (e.g., cetirizine or loratadine) may provide symptomatic relief for mild allergic-type itching, though patients should consult a pharmacist or GP before starting any new medication
